Cardiovascular Systems Inc (CSII) [Rocket]

Overview

Cardiovascular Systems Inc (CSII)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
05/08/2023	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/01/2023	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Jun-30-22	Jun-30-21	Jun-30-20	Jun-30-19	Jun-05-19	Jun-30-18	Jun-30-17	Jun-30-16
Revenues	236.2	259.0	236.5	248.0	248.0	217.0	204.9	178.2
Revenue growth	-8.8%	9.5%	-4.6%	14.3%		5.9%	15.0%	-1.9%
Cost of goods sold	63.4	61.1	48.8	47.7	47.7	39.5	39.4	35.4
Gross profit	172.8	197.8	187.8	200.3	200.3	177.6	165.5	142.8
Gross margin	73.1%	76.4%	79.4%	80.8%	80.8%	81.8%	80.8%	80.1%
Selling, general and administrative	170.5	167.5	170.0	167.7	167.7	148.6	144.1	162.5
Research and development	36.7	41.1	43.4	33.2	33.2	26.6	22.9	25.9
EBITA	-34.5	-10.7	-25.5	-0.5	-0.5	2.4	-1.3	-45.5
EBITA margin	-14.6%	-4.1%	-10.8%	-0.2%	-0.2%	1.1%	-0.6%	-25.5%
Amortization of intangibles	1.3	1.2	1.2	0.3	0.3	0.2	0.2	0.2
EBIT	-35.8	-11.9	-26.8	-0.8	-0.8	2.2	-1.5	-45.7
EBIT margin	-15.2%	-4.6%	-11.3%	-0.3%	-0.3%	1.0%	-0.8%	-25.7%
Pre-tax income	-36.6	-13.2	-27.0	-0.1	-0.1	1.8	-1.7	-55.9
Income taxes	0.3	0.3	0.2	0.2	0.2	0.1	0.1	0.1
Tax rate						7.2%
Net income	-36.9	-13.4	-27.2	-0.3	-0.3	1.7	-1.8	-56.0
Net margin	-15.6%	-5.2%	-11.5%	-0.1%	-0.1%	0.8%	-0.9%	-31.4%

Diluted EPS	($0.94)	($0.35)	($0.79)	($0.01)	($0.01)	$0.05	($0.06)	($1.72)
Shares outstanding (diluted)	39.2	38.8	34.3	33.5	33.5	33.6	32.4	32.5

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.